Mackenzie Financial’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,919	Closed	-$337K	–	1696
2024 Q2	$337K	Sell	4,919 -2,407	-33%	-$167K	﹤0.01%	1120
2024 Q1	$507K	Buy	7,326 +3,289	+81%	+$226K	﹤0.01%	1021
2023 Q4	$289K	Buy	+4,037	New	+$232K	﹤0.01%	1165
2023 Q3	–	Sell	-7,589	Closed	-$475K	–	1612
2023 Q2	$475K	Buy	7,589 +1,946	+34%	+$121K	﹤0.01%	1034
2023 Q1	$306K	Hold	5,643	–	–	﹤0.01%	1177
2022 Q4	$299K	Sell	5,643 -298	-5%	-$14.9K	﹤0.01%	1092
2022 Q3	$276K	Sell	5,941 -50,989	-90%	-$2.66M	﹤0.01%	1123
2022 Q2	$3.25M	Buy	56,930 +52,389	+1,154%	+$2.97M	0.01%	618
2022 Q1	$278K	Buy	4,541 +700	+18%	+$36.4K	﹤0.01%	1153
2021 Q4	$201K	Buy	+3,841	New	+$161K	﹤0.01%	1337